Come up with a name for your new list and we'll add to it:
Contraline raised a round of funding on June 13, 2016. Investors include
Center for Innovative Technology.
Contraline is a biotechnology company developing a long-lasting, nonhormonal, and reversible male contraceptive. Contraline's first product, Echo-V, is a polymer gel that is implanted nonsurgically vi…